This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2019 Mar;44(3):10-12.

doi: 10.1097/01.NPR.0000550252.04526.79.

Medication-assisted treatment for opioid use disorder

Louise Kaplan¹

Affiliations

Affiliation

¹ Louise Kaplan is an associate professor at Washington State University Vancouver, Vancouver, Wash., and family NP at Tumwater Family Practice Clinic, Tumwater, Wash.

PMID: 30585906
DOI: 10.1097/01.NPR.0000550252.04526.79

Medication-assisted treatment for opioid use disorder

Louise Kaplan. Nurse Pract. 2019 Mar.

. 2019 Mar;44(3):10-12.

doi: 10.1097/01.NPR.0000550252.04526.79.

Author

Louise Kaplan¹

Affiliation

¹ Louise Kaplan is an associate professor at Washington State University Vancouver, Vancouver, Wash., and family NP at Tumwater Family Practice Clinic, Tumwater, Wash.

PMID: 30585906
DOI: 10.1097/01.NPR.0000550252.04526.79

No abstract available

PubMed Disclaimer

Similar articles

At a Tipping Point: Nurses Can Push Narcan to the Mainstream and Save Lives.
Moore DJ. Moore DJ. J Addict Nurs. 2017 Oct/Dec;28(4):173-176. doi: 10.1097/JAN.0000000000000192. J Addict Nurs. 2017. PMID: 29200042 No abstract available.
Recovery Beyond Buprenorphine: Nurse-Led Group Therapy.
Fogger SA, Lehmann K. Fogger SA, et al. J Addict Nurs. 2017 Jul/Sep;28(3):152-156. doi: 10.1097/JAN.0000000000000180. J Addict Nurs. 2017. PMID: 28863059 Review.
Medication-Based Treatment to Address Opioid Use Disorder.
Leshner AI, Dzau VJ. Leshner AI, et al. JAMA. 2019 Jun 4;321(21):2071-2072. doi: 10.1001/jama.2019.5523. JAMA. 2019. PMID: 31046072 No abstract available.
Opioids: A public health emergency.
Kaplan L. Kaplan L. Nurse Pract. 2018 Apr 19;43(4):12-13. doi: 10.1097/01.NPR.0000531073.34429.81. Nurse Pract. 2018. PMID: 29509652 No abstract available.
Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.
Connery HS. Connery HS. Harv Rev Psychiatry. 2015 Mar-Apr;23(2):63-75. doi: 10.1097/HRP.0000000000000075. Harv Rev Psychiatry. 2015. PMID: 25747920 Review.

See all similar articles

Cited by

Negative allosteric modulation of CB1 cannabinoid receptor signalling decreases intravenous morphine self-administration and relapse in mice.
Oliva I, Kazi F, Cantwell LN, Thakur GA, Crystal JD, Hohmann AG. Oliva I, et al. Addict Biol. 2024 Aug;29(8):e13429. doi: 10.1111/adb.13429. Addict Biol. 2024. PMID: 39109814 Free PMC article.
Discovery of 6α-Thiazolylcarboxamidonaltrexamine Derivative (NTZ) as a Potent and Central Nervous System Penetrant Opioid Receptor Modulator with Drug-like Properties for Potential Treatment of Opioid Use Disorder.
Huang B, Ma H, Pagare PP, Li M, Mendez RE, Gillespie JC, Poklis JL, Halquist MS, Stevens DL, Dewey WL, Selley DE, Zhang Y. Huang B, et al. ACS Pharmacol Transl Sci. 2024 Dec 5;7(12):4165-4182. doi: 10.1021/acsptsci.4c00593. eCollection 2024 Dec 13. ACS Pharmacol Transl Sci. 2024. PMID: 39698260
Latent class analysis of perceived stigma among older adults receiving medications for opioid use disorder.
Mitchell MM, Angelo S, Akinwolere OG, Perkins MM, Bender AA. Mitchell MM, et al. J Subst Use Addict Treat. 2024 Jan;156:209187. doi: 10.1016/j.josat.2023.209187. Epub 2023 Oct 18. J Subst Use Addict Treat. 2024. PMID: 37858796 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information